| 1 |
Verma S, Goand UK, Garg R, Husain A, Katekar RA, Riyazuddin M, Dadge S, Gayen JR. LC-MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies. Bioanalysis 2023. [PMID: 36916612 DOI: 10.4155/bio-2022-0239] [Reference Citation Analysis]
|
| 2 |
Girisa S, Parama D, Harsha C, Banik K, Kunnumakkara AB. Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. Exploration of Targeted Anti-tumor Therapy 2020;1. [DOI: 10.37349/etat.2020.00019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 3 |
Seleem MA, Rodrigues de Almeida N, Chhonker YS, Murry DJ, Guterres ZDR, Blocker AM, Kuwabara S, Fisher DJ, Leal ES, Martinefski MR, Bollini M, Monge ME, Ouellette SP, Conda-Sheridan M. Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases. J Med Chem 2020;63:4370-87. [PMID: 32227948 DOI: 10.1021/acs.jmedchem.0c00371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 4 |
Balhara A, Ladumor M, Singh DK, Praneetha P, Preethi J, Pokharkar S, Deshpande AY, Giri S, Singh S. In vitro evaluation of reactive nature of E- and Z-guggulsterones and their metabolites in human liver microsomes using UHPLC-Orbitrap mass spectrometer. J Pharm Biomed Anal 2020;186:113275. [PMID: 32247160 DOI: 10.1016/j.jpba.2020.113275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Riyazuddin M, Husain A, Verma S, Katekar R, Garg R, Kumar S, Satish S, Maurya R, Narender T, Chattopadhyay N, Gayen JR. Simultaneous quantification of five biomarkers in ethanolic extract of Cassia occidentalis Linn. stem using liquid chromatography tandem mass spectrometry: application to its pharmacokinetic studies. RSC Adv 2020;10:4579-88. [DOI: 10.1039/c9ra07482a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Miller CN, Samuels JS, Azhar Y, Parmar A, Shashidharamurthy R, Rayalam S. Guggulsterone Activates Adipocyte Beiging through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated through RAW264.7 Macrophages. Medicines (Basel) 2019;6:E22. [PMID: 30709026 DOI: 10.3390/medicines6010022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 7 |
Chhonker YS, Chandasana H, Bala V, Mukkavilli R, Kumar D, Vangala S, Bhatta RS. In-vitro metabolism, CYP profiling and metabolite identification of E- and Z- guggulsterone, a potent hypolipidmic agent. Journal of Pharmaceutical and Biomedical Analysis 2018;160:202-11. [DOI: 10.1016/j.jpba.2018.06.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Zhang ZY, Zhang H, Liu D, Lu YY, Wang X, Li P, Lou YQ, Yang BX, Lou YX, Lu C, Zhang Q, Zhang GL. Pharmacokinetics, Tissue Distribution and Excretion of a Novel Diuretic (PU-48) in Rats. Pharmaceutics 2018;10:E124. [PMID: 30096833 DOI: 10.3390/pharmaceutics10030124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
